EDGAR Pro - LYELL IMMUNOPHARMA, INC.

Welcome

Help

About EDGAR® Online

Recent Companies

Company

Summary

Company Info

Risk Factors
(10-Q 05/06/24)

Auditor Opinion & Info

Company News

Industry

Transcripts

Stock Info

Last Trade
$1.45 (+0.07/5.07%)

Interactive Charting

Financials

Balance Sheet

Income Statement

Cash Flow

Financial Ratios

Financial Comparison

SEC Filings

Last MD&A
(10-Q 05/06/24)

Last Quarterly Filing
(10-Q 05/06/24)

Last Annual Filing
(10-K 02/28/24)

Last Proxy Filing
(DEFA14A 04/22/24)

All Filings
(Excluding Insider)

All Filings

All Quarterly Filings

All Annual Filings

All Proxy Filings

SEC Comment Letters
and Correspondence

Ownership

Summary

Insider Trades

Latest Insider Filings

Institutional Holders

5% Ownership Filings

Company People

Executive Compensation

All Company People

Subscribe Now to unlock all the Features!

Learn More

Get Company Summary for

Add Summary to Dashboard

Add Filings Alert

LYELL IMMUNOPHARMA, INC. (LYEL)

Summary

Institutional Holders

Total Number of Holders	140
% of Shares Outstanding	49.81%
Total Shares Held	126,988,686
Total Value of Holdings	$184,133,594.70
Net Activity	1,477,543

Latest Company News		Date

(Quotes provided by Thomson Reuters are delayed by 15 minutes or more.)

EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.

EPWWEB-EXT04